Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Lung Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 229 articles: HTML format Text format

Single Articles

March 2020
1. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
   Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
   Int J Radiat Oncol Biol Phys. 2020;106:455-459.
   PubMed     Text format    
   
   
   
2. HAGAN M, Kapoor R, Michalski J, Sandler H, et al
   VA-Radiation Oncology Quality Surveillance Program.
   Int J Radiat Oncol Biol Phys. 2020;106:639-647.
   PubMed     Text format     Abstract available
   
   
   
3. VAN MARLEN P, Dahele M, Folkerts M, Abel E, et al
   Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
   Int J Radiat Oncol Biol Phys. 2020;106:621-629.
   PubMed     Text format     Abstract available
   
   
   February 2020
4. CORNELL M, Kaderka R, Hild SJ, Ray XJ, et al
   Noninferiority Study of Automated Knowledge-Based Planning Versus Human-Driven Optimization Across Multiple Disease Sites.
   Int J Radiat Oncol Biol Phys. 2020;106:430-439.
   PubMed     Text format     Abstract available
   
   
   
5. TANG C, Lee WC, Reuben A, Chang L, et al
   Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial.
   Int J Radiat Oncol Biol Phys. 2020;106:349-357.
   PubMed     Text format     Abstract available
   
   
   
6. TRIFILETTI DM, Ballman KV, Brown PD, Anderson SK, et al
   Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
   Int J Radiat Oncol Biol Phys. 2020;106:255-260.
   PubMed     Text format     Abstract available
   
   
   
7. GREWAL AS, Min EJ, Long Q, Grewal SK, et al
   Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy.
   Int J Radiat Oncol Biol Phys. 2020;106:358-368.
   PubMed     Text format     Abstract available
   
   
   January 2020
8. PENG J, Pond G, Donovan E, Ellis PM, et al
   A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2020 Jan 29. pii: S0360-3016(19)34545.
   PubMed     Text format     Abstract available
   
   
   
9. DAUTRUCHE A, Filion E, Mathieu D, Bahig H, et al
   To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
   Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30124.
   PubMed     Text format     Abstract available
   
   
   
10. O'REILLY S, Jain V, Huang Q, Cheng C, et al
    Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30073.
    PubMed     Text format     Abstract available
    
    
    
11. MANYAM BV, Verdecchia K, Videtic GMM, Zhuang T, et al
    Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30068.
    PubMed     Text format     Abstract available
    
    
    
12. VINOGRADSKIY Y, Diot Q, Jones B, Castillo R, et al
    Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 23. pii: S0360-3016(19)34526.
    PubMed     Text format     Abstract available
    
    
    
13. ONG WL, Foroudi F, Milne RL, Millar JL, et al
    Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia.
    Int J Radiat Oncol Biol Phys. 2020;106:61-66.
    PubMed     Text format     Abstract available
    
    
    
14. DUIJM M, van der Voort van Zyp NC, van de Vaart P, Oomen-de Hoop E, et al
    Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Int J Radiat Oncol Biol Phys. 2020;106:73-81.
    PubMed     Text format     Abstract available
    
    
    
15. LI R, Shinde A, Novak J, Vapiwala N, et al
    Temporal Trends of Resident Experience in External Beam Radiation Therapy Cases: Analysis of ACGME Case Logs from 2007 to 2018.
    Int J Radiat Oncol Biol Phys. 2020;106:37-42.
    PubMed     Text format     Abstract available
    
    
    December 2019
16. FENWICK JD, Landau DB, Baker A, Bates AT, et al
    Long-term results from the IDEAL-CRT phase 1/2 trial of isotoxically dose-escalated radiation therapy and concurrent chemotherapy for stage II/III non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2019 Dec 3. pii: S0360-3016(19)34456.
    PubMed     Text format     Abstract available
    
    
    November 2019
17. QIN A, Rengan R, Lee S, Santana-Davila R, et al
    A Pilot Study of Atezolizumab plus Hypofractionated Image-guided Radiotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Nov 19. pii: S0360-3016(19)34007.
    PubMed     Text format     Abstract available
    
    
    October 2019
18. WANG XS, Shi Q, Mendoza T, Lin S, et al
    Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-small Cell Lung Cancer: A Phase II Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019 Oct 15. pii: S0360-3016(19)33883.
    PubMed     Text format     Abstract available
    
    
    
19. KANG J, Ning MS, Feng H, Li H, et al
    Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms.
    Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33861.
    PubMed     Text format     Abstract available
    
    
    September 2019
20. OHNISHI K, Nakamura N, Harada H, Tokumaru S, et al
    Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Int J Radiat Oncol Biol Phys. 2019 Sep 30. pii: S0360-3016(19)33837.
    PubMed     Text format     Abstract available
    
    
    
21. OZSAHIN M, Slotman BJ, Bourhis J
    Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;105:233-234.
    PubMed     Text format    
    
    
    
22. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed     Text format    
    
    
    
23. HOPPE RT
    20 Gy Versus 30 Gy: Will it Make a Difference?
    Int J Radiat Oncol Biol Phys. 2019;105:102-103.
    PubMed     Text format    
    
    
    August 2019
24. CHO Y, Park S, Byun HK, Lee CG, et al
    Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Aug 30. pii: S0360-3016(19)33733.
    PubMed     Text format     Abstract available
    
    
    
25. SINGH AK, Gomez-Suescun JA, Stephans KL, Bogart JA, et al
    One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2019 Aug 22. pii: S0360-3016(19)33653.
    PubMed     Text format     Abstract available
    
    
    
26. LIU C, Sun B, Hu X, Zhang Y, et al
    Stereotactic ablative radiotherapy for pulmonary recurrence-based oligometastatic non-small cell lung cancer: survival and prognostic value of regulatory T cells.
    Int J Radiat Oncol Biol Phys. 2019 Aug 19. pii: S0360-3016(19)33646.
    PubMed     Text format     Abstract available
    
    
    
27. DING X, Cheng J, Pang Q, Wei X, et al
    BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM/CHK1 inhibition.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33642.
    PubMed     Text format     Abstract available
    
    
    
28. OHRI N, Halmos B, Bodner WR, Cheng H, et al
    Daily step counts: A new prognostic factor in locally advanced non-small cell lung cancer?
    Int J Radiat Oncol Biol Phys. 2019 Aug 6. pii: S0360-3016(19)33560.
    PubMed     Text format     Abstract available
    
    
    
29. PALMA D, Zhang T
    In Reply to Banfill et al.
    Int J Radiat Oncol Biol Phys. 2019;104:1180.
    PubMed     Text format    
    
    
    
30. BANFILL KE, McWilliam A, van Herk M, Faivre-Finn C, et al
    In Regard to Zhang et al.
    Int J Radiat Oncol Biol Phys. 2019;104:1179-1180.
    PubMed     Text format    
    
    
    
31. BILLFALK-KELLY A, Yu E, Su J, O'Sullivan B, et al
    Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2019;104:1017-1027.
    PubMed     Text format     Abstract available
    
    
    July 2019
32. LIN SH
    The Role of Adjuvant Radiotherapy for Resected Non-Small Cell Lung Cancer in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2019;104:712-713.
    PubMed     Text format    
    
    
    
33. NIAZI MZ, Golden DW
    Thoracic Postoperative Radiation Therapy: To Treat or Not to Treat?
    Int J Radiat Oncol Biol Phys. 2019;104:710.
    PubMed     Text format    
    
    
    
34. FINAZZI T, Palacios MA, Spoelstra FOB, Haasbeek CJA, et al
    Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2019;104:933-941.
    PubMed     Text format     Abstract available
    
    
    
35. BADIYAN SN, Robinson CG, Bradley JD
    Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem?
    Int J Radiat Oncol Biol Phys. 2019;104:590-592.
    PubMed     Text format    
    
    
    
36. SAMPATH S, Rahmanuddin S, Sahoo P, Frankel P, et al
    Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: a prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33424.
    PubMed     Text format     Abstract available
    
    
    
37. MENZEL P, Theodosopoulos P
    A Caudate Conundrum.
    Int J Radiat Oncol Biol Phys. 2019;104:481-482.
    PubMed     Text format    
    
    
    June 2019
38. XIE L, Bao X, Cai T, Silva SG, et al
    Elevated risk of radiotherapy-associated second malignant neoplasms in young African American women survivors of stage I-IIIA breast cancer.
    Int J Radiat Oncol Biol Phys. 2019 Jun 12. pii: S0360-3016(19)30835.
    PubMed     Text format     Abstract available
    
    
    
39. LADBURY CJ, Rusthoven CG, Camidge DR, Kavanagh BD, et al
    Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019 Jun 5. pii: S0360-3016(19)30818.
    PubMed     Text format     Abstract available
    
    
    
40. VIDETIC GM
    In Reply to Yilmaz et al.
    Int J Radiat Oncol Biol Phys. 2019;104:467.
    PubMed     Text format    
    
    
    
41. YILMAZ MT, Hurmuz P, Cengiz M
    In Regard to Videtic et al.
    Int J Radiat Oncol Biol Phys. 2019;104:466-467.
    PubMed     Text format    
    
    
    
42. LAVIGNE J, Suissa A, Verger N, Dos Santos M, et al
    Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1alpha Endothelial Deletion.
    Int J Radiat Oncol Biol Phys. 2019;104:279-290.
    PubMed     Text format     Abstract available
    
    
    May 2019
43. FRANCESCHINI D, De Rose F, Franzese C, Comito T, et al
    Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:111-121.
    PubMed     Text format     Abstract available
    
    
    April 2019
44. SIVA S, Ball DL
    Single Fraction SBRT for Early Stage Lung Cancer-Less is More?
    Int J Radiat Oncol Biol Phys. 2019;103:1085-1087.
    PubMed     Text format    
    
    
    
45. RUSTHOVEN CG
    Small Cell Lung Cancer: PCI Uncertainty and Emerging Radiosurgery Interest.
    Int J Radiat Oncol Biol Phys. 2019;103:1034-1035.
    PubMed     Text format    
    
    
    
46. SHINDE A, Amini A
    Challenging Current Conventions: Up-Front Stereotactic Radiosurgery Alone for Limited Brain Metastases in Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:1031-1032.
    PubMed     Text format    
    
    
    
47. GASPAR LE
    A Gray Zone Regarding Gray Matter.
    Int J Radiat Oncol Biol Phys. 2019;103:1033-1034.
    PubMed     Text format    
    
    
    
48. WEGNER RE, Hasan S
    Observe the Brain and Preserve the Mind.
    Int J Radiat Oncol Biol Phys. 2019;103:1033.
    PubMed     Text format    
    
    
    
49. LARSEN F, Terlizzi M, Linacre V, Sargos P, et al
    Radiation Therapy in Resectable Intrathoracic Sarcomas. A Rare Cancer Network Study.
    Int J Radiat Oncol Biol Phys. 2019;103:1175-1181.
    PubMed     Text format     Abstract available
    
    
    March 2019
50. PALMA D, Daly M, Urbanic J, Giuliani M, et al
    Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?
    Int J Radiat Oncol Biol Phys. 2019;103:788-791.
    PubMed     Text format    
    
    
    
51. MA JT, Liu Y, Sun L, Milano MT, et al
    Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.
    Int J Radiat Oncol Biol Phys. 2019;103:843-850.
    PubMed     Text format     Abstract available
    
    
    
52. MIYAWAKI E, Kenmotsu H, Mori K, Harada H, et al
    Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-mutant NSCLC with Brain Metastases Stratified by Number of Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2019 Mar 6. pii: S0360-3016(19)30307.
    PubMed     Text format     Abstract available
    
    
    February 2019
53. PALMA G, Monti S, Xu T, Scifoni E, et al
    Spatial Dose Patterns Associated with Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Radiation Therapy with Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 26. pii: S0360-3016(19)30274.
    PubMed     Text format     Abstract available
    
    
    
54. TUCKER SL, Xu T, Paganetti H, Deist T, et al
    Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019;103:403-410.
    PubMed     Text format     Abstract available
    
    
    January 2019
55. BERLIN E, Buckstein M, Yip R, Yankelevitz DF, et al
    Definitive Radiation for Stage I lung cancer in a screened population: Results from the I-ELCAP.
    Int J Radiat Oncol Biol Phys. 2019 Jan 21. pii: S0360-3016(19)30110.
    PubMed     Text format     Abstract available
    
    
    
56. ZHANG TW, Snir J, Boldt RG, Rodrigues GB, et al
    Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature.
    Int J Radiat Oncol Biol Phys. 2019 Jan 7. pii: S0360-3016(18)34226.
    PubMed     Text format     Abstract available
    
    
    
57. 
    Erratum to: Kasmann L, Manapov F. Immune Checkpoint Inhibition Combined With Intracranial Stereotactic Radiation Therapy in Non-Small Cell Lung Cancer: Is There an Increased Rate of Radionecrosis or Not? Int J Radiat Oncol Biol Phys 2018;102:465.
    Int J Radiat Oncol Biol Phys. 2019;103:286.
    PubMed     Text format    
    
    
    
58. SAHGAL A
    Lead with Surgery, SBRT to Follow.
    Int J Radiat Oncol Biol Phys. 2019;103:16-17.
    PubMed     Text format    
    
    
    
59. STAM B, Kwint M, Guckenberger M, Mantel F, et al
    Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.
    Int J Radiat Oncol Biol Phys. 2019;103:132-141.
    PubMed     Text format     Abstract available
    
    
    
60. KALAPURAKAL JA, Gopalakrishnan M, Walterhouse DO, Rigsby CK, et al
    Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2019;103:28-37.
    PubMed     Text format     Abstract available
    
    
    
61. HOF SV, Delaney AR, Tekatli H, Twisk J, et al
    Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm.
    Int J Radiat Oncol Biol Phys. 2019;103:259-267.
    PubMed     Text format     Abstract available
    
    
    December 2018
62. VIDETIC GM, Paulus R, Singh AK, Chang JY, et al
    Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Dec 1. pii: S0360-3016(18)34048.
    PubMed     Text format     Abstract available
    
    
    November 2018
63. YILMAZ U, Wong TZ, Marks LB
    How Good Is Positron Emission Tomography at Detecting Previously-Occult Metastatic Lung Cancer at Diagnosis?
    Int J Radiat Oncol Biol Phys. 2018;102:716-717.
    PubMed     Text format    
    
    
    
64. DEMISSEI BG, Freedman G, Feigenberg SJ, Plastaras JP, et al
    Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer and lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33999.
    PubMed     Text format     Abstract available
    
    
    
65. SIO TT, Atherton PJ, Pederson LD, Zhen WK, et al
    Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33924.
    PubMed     Text format     Abstract available
    
    
    
66. YAMAMOTO M, Aiyama H, Koiso T, Watanabe S, et al
    Validity of a Recently-Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Brain Metastasis Patients Undergoing Multiple Radiosurgical Procedures.
    Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33925.
    PubMed     Text format     Abstract available
    
    
    
67. FRICK MA, Kao GD, Aguarin L, Chinniah C, et al
    Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.
    Int J Radiat Oncol Biol Phys. 2018;102:536-542.
    PubMed     Text format     Abstract available
    
    
    October 2018
68. PINDER-ARABPOUR A, Jones B, Castillo R, Castillo E, et al
    Characterizing Spatial Lung Function For Esophageal Cancer Patients Undergoing Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2018 Oct 26. pii: S0360-3016(18)33913.
    PubMed     Text format     Abstract available
    
    
    
69. YIN X, Mason J, Lobachevsky PN, Munforte L, et al
    Radiotherapy Modulates DNA Repair Efficiency in Peripheral Blood Mononuclear Cells Of Patients With Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Oct 9. pii: S0360-3016(18)33833.
    PubMed     Text format     Abstract available
    
    
    
70. FERRIS MJ, Jiang R, Behera M, Ramalingam SS, et al
    Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018;102:383-390.
    PubMed     Text format     Abstract available
    
    
    
71. VANDERSTRAETEN B, Goddeeris B, Vandecasteele K, van Eijkeren M, et al
    Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical Preference.
    Int J Radiat Oncol Biol Phys. 2018;102:443-450.
    PubMed     Text format     Abstract available
    
    
    September 2018
72. JIN P, Machiels M, Crama KF, Visser J, et al
    Dosimetric benefits of mid-position compared with internal target volume strategy for esophageal cancer radiation therapy.
    Int J Radiat Oncol Biol Phys. 2018 Sep 22. pii: S0360-3016(18)33804.
    PubMed     Text format     Abstract available
    
    
    
73. KELADA OJ, Decker RH, Nath SK, Johung KL, et al
    High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.
    Int J Radiat Oncol Biol Phys. 2018;102:174-183.
    PubMed     Text format     Abstract available
    
    
    August 2018
74. YANG P, Xu T, Gomez DR, Deng W, et al
    Patterns of Local-Regional Failure after Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy with Concurrent Chemotherapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Aug 27. pii: S0360-3016(18)33637.
    PubMed     Text format     Abstract available
    
    
    
75. PAZ A, Yamamoto N, Sakama M, Matsufuji N, et al
    Tumor control probability analysis for single fraction carbon ion radiotherapy of early-stage non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Aug 1. pii: S0360-3016(18)33466.
    PubMed     Text format     Abstract available
    
    
    July 2018
76. DIELEMAN EMT, Uitterhoeve ALJ, van Hoek MW, van Os RM, et al
    Concurrent daily Cisplatin and high dose radiotherapy in patients with stage III non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jul 25. pii: S0360-3016(18)31641.
    PubMed     Text format     Abstract available
    
    
    
77. BRADE AM, Wenz F, Koppe F, Lievens Y, et al
    Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2018;101:927-934.
    PubMed     Text format     Abstract available
    
    
    
78. BOONYAWAN K, Gomez DR, Komaki R, Xu Y, et al
    Clinical and Dosimetric Factors Predicting Grade >/=2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;101:919-926.
    PubMed     Text format     Abstract available
    
    
    
79. TORRE-BOUSCOULET L, Arroyo-Hernandez M, Martinez-Briseno D, Munoz-Montano WR, et al
    Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;101:910-918.
    PubMed     Text format     Abstract available
    
    
    
80. PETTY WJ, Urbanic JJ, Ahmed T, Hughes R, et al
    Long Term Outcomes of a Phase II Trial of Chemotherapy with Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jul 9. pii: S0360-3016(18)31401.
    PubMed     Text format     Abstract available
    
    
    
81. HURMUZ P, Ozyigit G
    In Regard to Nantavithya et al.
    Int J Radiat Oncol Biol Phys. 2018;101:744-745.
    PubMed     Text format    
    
    
    
82. GROSSHANS DR, Brown PD
    Chemotherapy Plus Proton or Photon Radiation on a Trial.
    Int J Radiat Oncol Biol Phys. 2018;101:518-519.
    PubMed     Text format    
    
    
    June 2018
83. ZHANG P, Yorke E, Mageras G, Rimner A, et al
    Validating a Predictive Atlas of Tumor Shrinkage for Adaptive Radiotherapy of Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 2. pii: S0360-3016(18)30908.
    PubMed     Text format     Abstract available
    
    
    
84. JOHNSON CN, Price GJ, Faivre-Finn C, Aznar MC, et al
    Residual setup errors towards the heart after image guidance linked with poorer survival in lung cancer patients: do we need stricter IGRT protocols?
    Int J Radiat Oncol Biol Phys. 2018 Jun 1. pii: S0360-3016(18)30904.
    PubMed     Text format     Abstract available
    
    
    May 2018
85. YAMAMOTO T, Kabus S, Bal M, Bzdusek K, et al
    Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 May 4. pii: S0360-3016(18)30741.
    PubMed     Text format     Abstract available
    
    
    
86. LOUIE AV
    A Small Window of Opportunity When Disease Is Limited in Extensive-Stage Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2018;101:7.
    PubMed     Text format    
    
    
    
87. GORE EM
    Select Patients With "Limited" Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively.
    Int J Radiat Oncol Biol Phys. 2018;101:6-7.
    PubMed     Text format    
    
    
    
88. WANG HH, Wu ZQ, Qian D, Zaorsky NG, et al
    Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo.
    Int J Radiat Oncol Biol Phys. 2018;101:49-62.
    PubMed     Text format     Abstract available
    
    
    
89. CHEN H, Laba JM, Boldt RG, Goodman CD, et al
    Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
    Int J Radiat Oncol Biol Phys. 2018;101:186-194.
    PubMed     Text format     Abstract available
    
    
    
90. BANG A, Kendal WS, Laurie SA, Cook G, et al
    Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.
    Int J Radiat Oncol Biol Phys. 2018 May 1. pii: S0360-3016(18)30736.
    PubMed     Text format     Abstract available
    
    
    April 2018
91. TOPKAN E, Selek U, Ozdemir Y, Yildirim BA, et al
    Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018 Apr 26. pii: S0360-3016(18)30720.
    PubMed     Text format     Abstract available
    
    
    
92. SHINTANI T, Matsuo Y, Iizuka Y, Mitsuyoshi T, et al
    A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
    Int J Radiat Oncol Biol Phys. 2018;100:1228-1236.
    PubMed     Text format     Abstract available
    
    
    
93. URBANIC JJ, McGarry RC, Daly ME, Palma DA, et al
    Locally Advanced Lung Cancer: Is It Time to Take Cardiac Protection Seriously in Radiation Planning?
    Int J Radiat Oncol Biol Phys. 2018;100:1091-1094.
    PubMed     Text format    
    
    
    
94. TRAN PT, Feng F, Ost P
    Live to SABR Another Day?
    Int J Radiat Oncol Biol Phys. 2018;100:1097.
    PubMed     Text format    
    
    
    March 2018
95. YEGYA-RAMAN N, Kim S, Deek MP, Li D, et al
    Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Mar 30. pii: S0360-3016(18)30557.
    PubMed     Text format     Abstract available
    
    
    
96. SCHAPIRA E, Hubbeling H, Yeap BY, Mehan WA Jr., et al
    Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2018 Mar 22. pii: S0360-3016(18)30542.
    PubMed     Text format     Abstract available
    
    
    
97. CHEN L, Douglass J, Kleinberg L, Ye X, et al
    Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:916-925.
    PubMed     Text format     Abstract available
    
    
    
98. ROACH MC, Robinson CG, Bradley JD
    Natural Disasters and the Importance of Minimizing Subsequent Radiation Therapy Interruptions for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018;100:836-837.
    PubMed     Text format    
    
    
    
99. FRENZEL T, Siekmann J, Grohmann C, Valentiner U, et al
    Locally Ablative Radiation Therapy of a Primary Human Small Cell Lung Cancer Tumor Decreases the Number of Spontaneous Metastases in Two Xenograft Models.
    Int J Radiat Oncol Biol Phys. 2018;100:1044-1056.
    PubMed     Text format     Abstract available
    
    
    
100. HURMUZ P, Cengiz M, Zorlu F, Akyol F, et al
     In Regard to Kumar et al.
     Int J Radiat Oncol Biol Phys. 2018;100:1079-1080.
     PubMed     Text format    
     
     
     
101. NANTAVITHYA C, Gomez DR, Wei X, Komaki R, et al
     Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30316.
     PubMed     Text format     Abstract available
     
     
     
102. LEE SH, Rimner A, Gelb E, Deasy JO, et al
     Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30330.
     PubMed     Text format     Abstract available
     
     
     
103. BARNEY CL, Scoville N, Allan E, Ayan A, et al
     Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
     Int J Radiat Oncol Biol Phys. 2018;100:748-755.
     PubMed     Text format     Abstract available
     
     
     
104. MARQUEZ C
     Observe, and Keep Chemotherapy Up the Sleeve.
     Int J Radiat Oncol Biol Phys. 2018;100:550.
     PubMed     Text format    
     
     
     
105. LOURENCO LM, Jiang Y, Drobnitzky N, Green M, et al
     PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice.
     Int J Radiat Oncol Biol Phys. 2018;100:767-775.
     PubMed     Text format     Abstract available
     
     
     
106. TEKATLI H, Duijm M, Oomen-de Hoop E, Verbakel W, et al
     Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
     Int J Radiat Oncol Biol Phys. 2018;100:738-747.
     PubMed     Text format     Abstract available
     
     
     February 2018
107. LIU C, Schild SE, Chang JY, Liao Z, et al
     Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Feb 14. pii: S0360-3016(18)30256.
     PubMed     Text format     Abstract available
     
     
     
108. VYFHUIS MAL, Burrows WM, Bhooshan N, Suntharalingam M, et al
     Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30250.
     PubMed     Text format     Abstract available
     
     
     
109. HAQUE W, Verma V, Fakhreddine M, Butler EB, et al
     Trends in Cardiac Mortality in Patients With Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018;100:470-477.
     PubMed     Text format     Abstract available
     
     
     
110. STEPHANS KL, Woody NM, Reddy CA, Varley M, et al
     Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018;100:462-469.
     PubMed     Text format     Abstract available
     
     
     January 2018
111. URBANIC JJ, Wang X, Bogart JA, Stinchcombe TE, et al
     Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).
     Int J Radiat Oncol Biol Phys. 2018 Jan 31. pii: S0360-3016(18)30109.
     PubMed     Text format     Abstract available
     
     
     
112. LEE J, Li B, Cui Y, Sun X, et al
     A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2018 Jan 10. pii: S0360-3016(18)30006.
     PubMed     Text format     Abstract available
     
     
     
113. POULSEN PR, Eley J, Langner U, Simone CB 2nd, et al
     Efficient Interplay Effect Mitigation for Proton Pencil Beam Scanning by Spot-Adapted Layered Repainting Evenly Spread out Over the Full Breathing Cycle.
     Int J Radiat Oncol Biol Phys. 2018;100:226-234.
     PubMed     Text format     Abstract available
     
     
     
114. ITO K, Shimizuguchi T, Nihei K, Furuya T, et al
     Patterns of Intraosseous Recurrence After Stereotactic Body Radiation Therapy for Coxal Bone Metastasis.
     Int J Radiat Oncol Biol Phys. 2018;100:159-161.
     PubMed     Text format     Abstract available
     
     
     December 2017
115. BERNARD V, Bishop AJ, Allen PK, Amini B, et al
     Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
     Int J Radiat Oncol Biol Phys. 2017;99:1207-1215.
     PubMed     Text format     Abstract available
     
     
     
116. KELLER A, Dore M, Cebula H, Thillays F, et al
     Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
     Int J Radiat Oncol Biol Phys. 2017;99:1179-1189.
     PubMed     Text format     Abstract available
     
     
     November 2017
117. EVERITT S, Ball D, Hicks RJ, Callahan J, et al
     Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survi
     Int J Radiat Oncol Biol Phys. 2017;99:947-955.
     PubMed     Text format     Abstract available
     
     
     
118. NIEDZIELSKI JS, Yang J, Mohan R, Titt U, et al
     Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.
     Int J Radiat Oncol Biol Phys. 2017;99:1013-1020.
     PubMed     Text format     Abstract available
     
     
     
119. VAN DER VELDEN JM, Peters M, Verlaan JJ, Versteeg AL, et al
     Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
     Int J Radiat Oncol Biol Phys. 2017;99:859-866.
     PubMed     Text format     Abstract available
     
     
     
120. YU W, Tang C, Hobbs BP, Li X, et al
     Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Nov 15. pii: S0360-3016(17)34061.
     PubMed     Text format     Abstract available
     
     
     
121. JETER MD, Gomez D, Nguyen QN, Komaki R, et al
     Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer:
     Int J Radiat Oncol Biol Phys. 2017 Nov 3. pii: S0360-3016(17)34055.
     PubMed     Text format     Abstract available
     
     
     
122. KUMAR S, Feddock J, Li X, Shearer AJ, et al
     Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;99:652-659.
     PubMed     Text format     Abstract available
     
     
     October 2017
123. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
     Positron Emission Tomography-Adjusted Intensity Modulated Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Oct 28. pii: S0360-3016(17)34039.
     PubMed     Text format     Abstract available
     
     
     
124. ZHOU R, Xu T, Nguyen QN, Liu Y, et al
     Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017 Oct 12. pii: S0360-3016(17)33964.
     PubMed     Text format     Abstract available
     
     
     
125. WIJSMAN R, Dankers FJWM, Troost EGC, Hoffmann AL, et al
     Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:434-441.
     PubMed     Text format     Abstract available
     
     
     
126. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
     Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
     Int J Radiat Oncol Biol Phys. 2017;99:459-467.
     PubMed     Text format     Abstract available
     
     
     
127. VOGEL J, Lin L, Litzky LA, Berman AT, et al
     Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
     Int J Radiat Oncol Biol Phys. 2017;99:427-433.
     PubMed     Text format     Abstract available
     
     
     
128. JOCHEMS A, Deist TM, El Naqa I, Kessler M, et al
     Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.
     Int J Radiat Oncol Biol Phys. 2017;99:344-352.
     PubMed     Text format     Abstract available
     
     
     
129. BAHIG H, Campeau MP, Lapointe A, Bedwani S, et al
     Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning.
     Int J Radiat Oncol Biol Phys. 2017;99:334-343.
     PubMed     Text format     Abstract available
     
     
     
130. FAUGHT AM, Miyasaka Y, Kadoya N, Castillo R, et al
     Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:325-333.
     PubMed     Text format     Abstract available
     
     
     
131. MODIRI A, Sabouri P, Gu X, Timmerman R, et al
     Inversed-Planned Respiratory Phase Gating in Lung Conformal Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:317-324.
     PubMed     Text format     Abstract available
     
     
     September 2017
132. ERIKSSON M, Haag P, Brzozowska B, Lipka M, et al
     Analysis of Chromatin Opening in Heterochromatic Non-Small cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment.
     Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33933.
     PubMed     Text format     Abstract available
     
     
     
133. RONDEN MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, et al
     Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33935.
     PubMed     Text format     Abstract available
     
     
     
134. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
     Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
     Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
     PubMed     Text format    
     
     
     
135. SUN Y, Hawkins PG, Bi N, Dess RT, et al
     Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33836.
     PubMed     Text format     Abstract available
     
     
     
136. PATRICE GI, Lester-Coll NH, Yu JB, Amdahl J, et al
     Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
     Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33838.
     PubMed     Text format     Abstract available
     
     
     
137. KARKI K, Saraiya S, Hugo GD, Mukhopadhyay N, et al
     Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
     Int J Radiat Oncol Biol Phys. 2017;99:80-89.
     PubMed     Text format     Abstract available
     
     
     
138. NING MS, Tang L, Gomez DR, Xu T, et al
     Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;99:70-79.
     PubMed     Text format     Abstract available
     
     
     
139. VIVEKANANDAN S, Landau DB, Counsell N, Warren DR, et al
     The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;99:51-60.
     PubMed     Text format     Abstract available
     
     
     
140. DALY ME, Palma DA
     Prophylactic Cranial Irradiation for Small Cell Lung Cancer: New Insights.
     Int J Radiat Oncol Biol Phys. 2017;99:3-5.
     PubMed     Text format    
     
     
     
141. CHOI CYH, Wakelee HA, Neal JW, Pinder-Schenck MC, et al
     Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
     Int J Radiat Oncol Biol Phys. 2017;99:16-21.
     PubMed     Text format     Abstract available
     
     
     
142. FAUGHT AM, Yamamoto T, Castillo R, Castillo E, et al
     Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;99:202-209.
     PubMed     Text format     Abstract available
     
     
     August 2017
143. GORGISYAN J, Munck Af Rosenschold P, Perrin R, Persson GF, et al
     Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33779.
     PubMed     Text format     Abstract available
     
     
     
144. CHURILLA TM, Ballman KV, Brown PD, Twohy EL, et al
     Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
     Int J Radiat Oncol Biol Phys. 2017 Aug 5. pii: S0360-3016(17)33691.
     PubMed     Text format     Abstract available
     
     
     
145. MCMILLAN MT, Ojerholm E, Verma V, Higgins KA, et al
     Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:1142-1152.
     PubMed     Text format     Abstract available
     
     
     
146. SHAVERDIAN N, Yoo SM, Cook R, Chang EM, et al
     Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.
     Int J Radiat Oncol Biol Phys. 2017;98:1153-1161.
     PubMed     Text format     Abstract available
     
     
     
147. KIM TH, Kim MH, Kim BJ, Park SI, et al
     Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
     PubMed     Text format     Abstract available
     
     
     July 2017
148. FANG P, He W, Gomez DR, Hoffman KE, et al
     Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
     Int J Radiat Oncol Biol Phys. 2017;98:748-757.
     PubMed     Text format     Abstract available
     
     
     
149. MIDDELBURG JG, Mast ME, de Kroon M, Jobsen JJ, et al
     Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:843-849.
     PubMed     Text format     Abstract available
     
     
     
150. WAHL DR, Nguyen PL, Santiago M, Yousefi K, et al
     Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
     Int J Radiat Oncol Biol Phys. 2017;98:726-732.
     PubMed     Text format     Abstract available
     
     
     
151. JAN N, Guy C, Reshko LB, Hugo GD, et al
     Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:683-690.
     PubMed     Text format     Abstract available
     
     
     
152. CHEN H, Senan S, Nossent EJ, Boldt RG, et al
     Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
     Int J Radiat Oncol Biol Phys. 2017;98:622-631.
     PubMed     Text format     Abstract available
     
     
     
153. WANG S, Campbell J, Stenmark MH, Zhao J, et al
     Plasma Levels of IL-8 and TGF-beta1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
     Int J Radiat Oncol Biol Phys. 2017;98:615-621.
     PubMed     Text format     Abstract available
     
     
     
154. EZE C, Roengvoraphoj O, Manapov F
     Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:612-614.
     PubMed     Text format    
     
     
     
155. REDMOND KJ, Hales RK, Anderson-Keightly H, Zhou XC, et al
     Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:603-611.
     PubMed     Text format     Abstract available
     
     
     
156. PRESS RH, Boselli DM, Symanowski JT, Lankford SP, et al
     External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2017;98:632-638.
     PubMed     Text format     Abstract available
     
     
     
157. RIEBER J, Abbassi-Senger N, Adebahr S, Andratschke N, et al
     Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
     Int J Radiat Oncol Biol Phys. 2017;98:511-520.
     PubMed     Text format     Abstract available
     
     
     June 2017
158. PAUL J, Yang C, Wu H, Tai A, et al
     Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography.
     Int J Radiat Oncol Biol Phys. 2017;98:463-472.
     PubMed     Text format     Abstract available
     
     
     
159. HELOU J, Thibault I, Poon I, Chiang A, et al
     Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
     Int J Radiat Oncol Biol Phys. 2017;98:419-427.
     PubMed     Text format     Abstract available
     
     
     
160. BASCH E, Pugh SL, Dueck AC, Mitchell SA, et al
     Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
     Int J Radiat Oncol Biol Phys. 2017;98:409-418.
     PubMed     Text format     Abstract available
     
     
     
161. BANG A, Wilhite TJ, Pike LRG, Cagney DN, et al
     Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:344-351.
     PubMed     Text format     Abstract available
     
     
     May 2017
162. YAN SX, Qureshi MM, Truong MT, Mak KS, et al
     Patterns of Care and Survival Outcomes in Stage II Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database.
     Int J Radiat Oncol Biol Phys. 2017;98:251.
     PubMed     Text format    
     
     
     
163. DEVITT M, Hall R, Gentzler RD
     Peripheral Blood Cell Free DNA to Monitor Mutational Response in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:250.
     PubMed     Text format    
     
     
     
164. FAVE X, Zhang L, Yang J, Mackin D, et al
     Using Pretreatment Radiomics and Delta-Radiomics Features to Predict Non-Small Cell Lung Cancer Patient Outcomes.
     Int J Radiat Oncol Biol Phys. 2017;98:249.
     PubMed     Text format    
     
     
     
165. LAN M, Xu T, Gomez DR, Jeter MD, et al
     Association Between LGALS3 Gene Polymorphisms and Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:249-250.
     PubMed     Text format    
     
     
     
166. GUTTMANN DM, Doucette A, Gabriel PE, Morrissette JJD, et al
     Patterns of Failure in Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Implications for the Role of Definitive Local Therapy to the Primary Tumor.
     Int J Radiat Oncol Biol Phys. 2017;98:248-249.
     PubMed     Text format    
     
     
     
167. AHERNE N, Tune D, Ross A, Dwyer P, et al
     Hippocampal Avoidance Prophylactic Cranial Irradiation in Small Cell Lung Carcinoma.
     Int J Radiat Oncol Biol Phys. 2017;98:248.
     PubMed     Text format    
     
     
     
168. NI L, Koshy M, Connell PP, Hubert G, et al
     Impact of Cardiac Dose on Cardiac Events and Survival in Unresectable Lung Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:247.
     PubMed     Text format    
     
     
     
169. SONI PD, Boonstra PS, Schipper M, Bazzi L, et al
     Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:247-248.
     PubMed     Text format    
     
     
     
170. CHEN H, Senan S, Nossent EJ, Boldt G, et al
     Treatment-Related Toxicity in Patients with Early Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic Review.
     Int J Radiat Oncol Biol Phys. 2017;98:245-246.
     PubMed     Text format    
     
     
     
171. XU T, Xu Y, Huo J, Yang P, et al
     Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:245.
     PubMed     Text format    
     
     
     
172. ZENG H, Li R, Hu C, Meng X, et al
     Hyperfractionated Accelerated Radiation Therapy May Increase Risk for Brain Metastases in Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:244.
     PubMed     Text format    
     
     
     
173. WEN Q, Meng X, Sun X, Hu M, et al
     Evaluation of Clinical and Demographic Factors Associated with Platinum-Sensitivity Status and Survival in Limited-Stage Small Cell Lung Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:243.
     PubMed     Text format    
     
     
     
174. ROUNTREE CA, Zahra A, Russo JK, O'Keefe J, et al
     Once- (QD) Versus Twice-Daily (BID) Radiation Therapy (RT) Plus Concurrent Chemotherapy for Limited-Stage (LS) Small-Cell Lung Cancer (SCLC): A Comparative Outcomes Analysis.
     Int J Radiat Oncol Biol Phys. 2017;98:243-244.
     PubMed     Text format    
     
     
     
175. ERKMEN C, Mitchell M
     Lung Cancer Screening in a Predominantly African-American Population.
     Int J Radiat Oncol Biol Phys. 2017;98:242-243.
     PubMed     Text format    
     
     
     
176. SHIN J, Russo GA
     Survival is Increasing for Patients with Stage I Non-Small Cell Lung Cancer Treated With Primary Radiation Therapy: We are Making Progress in the Era of Stereotactic Body Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:241.
     PubMed     Text format    
     
     
     
177. GOLDEN S, Thomas CR Jr, Slatore C
     It Wasn't as Bad as I Thought It Would Be: A Prospective, Qualitative Longitudinal Study of Early Stage Non-Small Cell Lung Cancer Patients After Treatment.
     Int J Radiat Oncol Biol Phys. 2017;98:241-242.
     PubMed     Text format    
     
     
     
178. JIN CJ, Kong W, MacKillop W
     Estimating the Need for Palliative Radiation Therapy for Lung Cancer: A Benchmarking Approach.
     Int J Radiat Oncol Biol Phys. 2017;98:240-241.
     PubMed     Text format    
     
     
     
179. DAVIS KL, Lenz C, Houghton K, Kaye JA, et al
     Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2017;98:239.
     PubMed     Text format    
     
     
     
180. G L, Agarwal V, Swamy K, Bhattacharjee S, et al
     Stereotactic Robotic Radiosurgery for 1-3 Brain Metastases from Non-Small Cell Lung Cancer: A Single Institutional Experience from South India.
     Int J Radiat Oncol Biol Phys. 2017;98:238.
     PubMed     Text format    
     
     
     
181. DAVIS KL, Lenz C, Houghton K, Kaye JA, et al
     Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:238-239.
     PubMed     Text format    
     
     
     
182. NGUYEN QN, Lu Y, Tang C, Chance WW, et al
     Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies?
     Int J Radiat Oncol Biol Phys. 2017;98:237.
     PubMed     Text format    
     
     
     
183. MO X
     Low Expression of 12 DNA Repair Genes was Associated With Better Disease-free Survival in Non-Small Cell Lung Cancer Patients Having Adjuvant Chemotherapy.
     Int J Radiat Oncol Biol Phys. 2017;98:237.
     PubMed     Text format    
     
     
     
184. YANG F, Chen L, Cheung W
     Attrition in the Treatment of Metastatic Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:237.
     PubMed     Text format    
     
     
     
185. HORNE ZD, Richman A, Clump DA 2nd, Burton SA, et al
     Mediastinal/Hilar Stereotactic Ablative Radiation Therapy for Primary and Oligorecurrent Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:237-238.
     PubMed     Text format    
     
     
     
186. GENTZLER RD, Mohindra NA, Hanna N, Chae YK, et al
     Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results.
     Int J Radiat Oncol Biol Phys. 2017;98:236.
     PubMed     Text format    
     
     
     
187. WEN Q, Meng X, Yue J, Ma C, et al
     Prediction of Early Response to Chemoradiation Therapy in Non-Small Cell Lung Cancer by Using Cone Beam Computed Tomography-Based Tumor Volume and Density Changes.
     Int J Radiat Oncol Biol Phys. 2017;98:235.
     PubMed     Text format    
     
     
     
188. ALJUMAILY R, Pleat N, George S, John S, et al
     A Histologic Guide in Treating Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Analysis.
     Int J Radiat Oncol Biol Phys. 2017;98:235.
     PubMed     Text format    
     
     
     
189. ACKERSON B, Boyle JM, Gu L, Kelsey CR, et al
     A Formal Assessment of the Dosimetric Advantages of Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:234.
     PubMed     Text format    
     
     
     
190. YANG P, Liao Z, Gomez DR, Xu T, et al
     Prospective Study of Marginal Recurrence in Patients with Non-Small Cell Lung Cancer After Proton or Photon Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:234.
     PubMed     Text format    
     
     
     
191. LIU J, Li C, Hu M, Lu J, et al
     Exploring Spatial Overlap of High-Uptake Regions Derived From Dual Tracer PET/CT Imaging Using 18F-FDG and 18F-FLT in Non-Small Cell Lung Cancer Patients: A Prospective Pilot Study.
     Int J Radiat Oncol Biol Phys. 2017;98:233.
     PubMed     Text format    
     
     
     
192. TAKEHANA K, Inokuchi H, Tsutsui K, Hiraoka M, et al
     Comparison of Radiation Dose of Induction Chemoradiation Therapy Followed by Surgery for Potentially Resectable Stage III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:233-234.
     PubMed     Text format    
     
     
     
193. NO H, Kikut J, Garrison G, Sidiropoulos N, et al
     Active Surveillance for Elderly Stage IA Non-Small Cell Lung Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:232.
     PubMed     Text format    
     
     
     
194. SINGH DP, Bergsma DP, Cummings MA, Hare MZ, et al
     Outcome with Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer Using 5 Fractions: Single Institution Experience of 106 Consecutive Patients.
     Int J Radiat Oncol Biol Phys. 2017;98:231-232.
     PubMed     Text format    
     
     
     
195. MANSUETI JR, Maillie S
     A Review of Non-Small Cell Lung Cancer Post-Treatment Follow-up Imaging Procedures with PET/CT Scans Versus CT Scans and the Effect on Patient Survival.
     Int J Radiat Oncol Biol Phys. 2017;98:231.
     PubMed     Text format    
     
     
     
196. POST CM, Verma V, Zhen W, Simone CB 2nd, et al
     Stereotactic Body Radiation Therapy for >/=5 cm Non-Small Cell Lung Cancer: Survey of United States Academic Thoracic Radiation Oncologists.
     Int J Radiat Oncol Biol Phys. 2017;98:230-231.
     PubMed     Text format    
     
     
     
197. BLUMENFELD PA, Kreinbrink PJ, Marwaha G
     Stereotactic Body Radiation Therapy Outcomes for Early Stage and Oligometastatic Non-Small Cell Lung Cancer Based on Molecular Profile.
     Int J Radiat Oncol Biol Phys. 2017;98:230.
     PubMed     Text format    
     
     
     
198. PEZZI TA, Mohamed ASR, Fuller CD, Blanchard P, et al
     Radiation Therapy is Independently Associated With Worse Survival After R0 Resection for Stage I-II Non-Small Cell Lung cancer: An Analysis of the National Cancer Data Base.
     Int J Radiat Oncol Biol Phys. 2017;98:230.
     PubMed     Text format    
     
     
     
199. CASSIDY RJ 3RD, Patel PR, Zhang X, Press RH, et al
     Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center Analysis.
     Int J Radiat Oncol Biol Phys. 2017;98:229-230.
     PubMed     Text format    
     
     
     
200. QIN A, Street L, Viglianti BL, Cease K, et al
     Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:228.
     PubMed     Text format    
     
     
     
201. NAGASAKA M, Sukari A
     Non-Small Cell Lung Cancer: Does Histology Matter?
     Int J Radiat Oncol Biol Phys. 2017;98:227-228.
     PubMed     Text format    
     
     
     
202. GAO Z, Meng X, Chen X, Sun X, et al
     Comparison of Tumor Volumes as Determined by Pathologic Examination and FLT-PET/CT Images of Non-Small Cell Lung Cancer: A Pilot Study.
     Int J Radiat Oncol Biol Phys. 2017;98:226-227.
     PubMed     Text format    
     
     
     
203. RAY M, Faris N, Rugless F, Smeltzer M, et al
     Multidisciplinary Care and the Use of Treatment Modalities for Non-Small Cell Lung Cancer (NSCLC) in a Large Community Healthcare Setting.
     Int J Radiat Oncol Biol Phys. 2017;98:226.
     PubMed     Text format    
     
     
     
204. ZHU HJ, Nichols RC Jr, Henderson RH, Morris CG, et al
     Impact of Unfavorable Factors on Outcomes Among Inoperable Stage II-IV Non-Small Cell Lung Cancer Patients Treated with Proton Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:225.
     PubMed     Text format    
     
     
     
205. GEBHARDT BJ, Horne ZD, Heron DE, Beriwal S, et al
     Standardization of Radiation Therapy Dose for Locally Advanced Non-Small Cell Lung Cancer Through Changes to a Lung Cancer Clinical Pathway in a Large, Integrated Comprehensive CancerCenter Network.
     Int J Radiat Oncol Biol Phys. 2017;98:225.
     PubMed     Text format    
     
     
     
206. SHARMA S, McMillan M, Doucette A, Cohen R, et al
     Impact of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small Cell Lung Cancer: A Propensity Score Matched Analysis of Patients in the National Cancer Database.
     Int J Radiat Oncol Biol Phys. 2017;98:224-225.
     PubMed     Text format    
     
     
     
207. AHMED KA, Grass GD, Creelan B, Gray J, et al
     Tolerability and Safety of Thoracic Radiation and Immune Checkpoint Inhibitors Among Patients with Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:224.
     PubMed     Text format    
     
     
     
208. GAO S, Kim A, Puchalski J, Bramley K, et al
     Indications for Invasive Mediastinal Staging in Patients with Early Non-Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed Tomography.
     Int J Radiat Oncol Biol Phys. 2017;98:223.
     PubMed     Text format    
     
     
     
209. SEPESI B, Cuentes EP, Canales JR, Behrens C, et al
     Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:223.
     PubMed     Text format    
     
     
     
210. DALWADI SM, Lewis G, Butler EB, Teh BS, et al
     Racial Disparities in the Treatment and Outcome of Stage I Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:223-224.
     PubMed     Text format    
     
     
     
211. JOLLY S, Sun Y, Hawkins PG, Bi N, et al
     Individualizing Radiation Dose in Locally Advanced Non-Small Cell Lung Cancer Patients Using Pretreatment Serum MicroRNA Signatures.
     Int J Radiat Oncol Biol Phys. 2017;98:222.
     PubMed     Text format    
     
     
     
212. CHINNIAH C, Aguarin L, Cheng P, DeCesaris C, et al
     Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;98:221.
     PubMed     Text format    
     
     
     
213. SINGH AK, Suescun JAG, Stephans KL, Bogart JA, et al
     A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2017;98:221-222.
     PubMed     Text format    
     
     
     
214. EDELMAN MJ, Wang X, Hodgson L, Cheney RT, et al
     Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance).
     Int J Radiat Oncol Biol Phys. 2017;98:220-221.
     PubMed     Text format    
     
     
     
215. PIOTROWSKA Z, Stirling K, Heist R, Campo M, et al
     Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy.
     Int J Radiat Oncol Biol Phys. 2017;98:220.
     PubMed     Text format    
     
     
     
216. FARRIS M, McTyre ER, Cramer CK, Hughes R, et al
     Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
     Int J Radiat Oncol Biol Phys. 2017;98:131-141.
     PubMed     Text format     Abstract available
     
     
     
217. WANG CJ, Christie A, Lin MH, Jung M, et al
     Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
     Int J Radiat Oncol Biol Phys. 2017;98:91-100.
     PubMed     Text format     Abstract available
     
     
     
218. CHEN WS, Townsend JP, Yu JB
     Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets.
     Int J Radiat Oncol Biol Phys. 2017;98:8-10.
     PubMed     Text format    
     
     
     March 2017
219. GUCKENBERGER M
     SBRT in eight fractions.
     Int J Radiat Oncol Biol Phys. 2017;97:653.
     PubMed     Text format    
     
     
     
220. PALMA DA
     An Ultracentral Lung Tumor.
     Int J Radiat Oncol Biol Phys. 2017;97:651.
     PubMed     Text format    
     
     
     
221. MELOTEK JM, Chmura SJ
     Oligometastasis-Directed Ablative Therapy: A Clinical Trial Question.
     Int J Radiat Oncol Biol Phys. 2017;97:448.
     PubMed     Text format    
     
     
     February 2017
222. MISHRA MV, Aggarwal S, Bentzen SM, Knight N, et al
     Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
     Int J Radiat Oncol Biol Phys. 2017;97:228-235.
     PubMed     Text format     Abstract available
     
     
     
223. GOMEZ D
     Induction Chemotherapy with Surgery and Post-operative Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;97:214.
     PubMed     Text format    
     
     
     
224. PALMA DA
     Plural Pleural Problems.
     Int J Radiat Oncol Biol Phys. 2017;97:213.
     PubMed     Text format    
     
     
     January 2017
225. KANEHIRA T, Matsuura T, Takao S, Matsuzaki Y, et al
     Impact of Real-Time Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study.
     Int J Radiat Oncol Biol Phys. 2017;97:173-181.
     PubMed     Text format     Abstract available
     
     
     
226. LEEMAN JE, Rimner A, Montecalvo J, Hsu M, et al
     Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2017;97:138-145.
     PubMed     Text format     Abstract available
     
     
     December 2016
227. VANDERWALDE NA, Deal AM, Comitz E, Stravers L, et al
     Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2016 Dec 2. pii: S0360-3016(16)33507.
     PubMed     Text format     Abstract available
     
     
     October 2016
228. SPERDUTO PW, Yang TJ, Beal K, Pan H, et al
     The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2016;96:406-13.
     PubMed     Text format     Abstract available
     
     
     September 2016
229. MILLER JA, Bennett EE, Xiao R, Kotecha R, et al
     Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
     Int J Radiat Oncol Biol Phys. 2016 Sep 1. pii: S0360-3016(16)33154.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: